INTERNATIONAL PATENT: FUDAN UNIVERSITY SHANGHAI CANCER CENTER, 复旦大学附属肿瘤医院 FILES APPLICATION FOR "NECTIN-4-TARGETING BICYCLIC PEPTIDE NUCLIDE LIGAND AND PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF"

GENEVA, Dec. 28 -- FUDAN UNIVERSITY SHANGHAI CANCER CENTER (270 Dong'an RoadXuhui District, Shanghai 200030), 复旦大学附属肿瘤医院 (中国上海市徐汇区东安路270号) filed a patent application (PCT/CN2025/099582) for "NECTIN-4-TARGETING BICYCLIC PEPTIDE NUCLIDE LIGAND AND PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF" on Jun 06, 2025. With publication no. WO/2025/261185, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organiza...